Q1 2024 Holdings
Filed 2024-05-15 | 70 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AC Immune SA(ACIU) | SHS | H00263105 | $368.8K | 124,589 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $402.7K | 79,588 | 0.0% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $882.2K | 166,460 | 0.1% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $1.1M | 1,388,944 | 0.1% |
| Repligen Corp(RGEN) | COM | 759916109 | $1.5M | 8,237 | 0.1% |
| Curevac N V | COM | N2451R105 | $1.6M | 515,691 | 0.1% |
| Aerovate Therapeutics Inc | COM | 008064107 | $1.6M | 54,150 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.9M | 283,034 | 0.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.9M | 22,818 | 0.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $2.0M | 1,305,140 | 0.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $2.3M | 97,065 | 0.2% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $2.4M | 5,828 | 0.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.5M | 142,075 | 0.2% |
| Morphosys AG | SPONSORED ADS | 617760202 | $3.0M | 165,924 | 0.2% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $3.1M | 12,178 | 0.2% |
| Avantor Inc(AVTR) | COM | 05352A100 | $3.2M | 125,394 | 0.2% |
| Alector Inc(ALEC) | COM | 014442107 | $3.2M | 536,171 | 0.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.3M | 18,557 | 0.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.5M | 88,934 | 0.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $3.9M | 290,000 | 0.3% |
| Waters Corp(WAT) | COM | 941848103 | $4.7M | 13,628 | 0.3% |
| Icon PLC(ICLR) | SHS | G4705A100 | $5.2M | 15,347 | 0.3% |
| Merus N V | COM | N5749R100 | $5.4M | 119,482 | 0.4% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $5.5M | 6,212,748 | 0.4% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $5.6M | 389,663 | 0.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $5.8M | 396,187 | 0.4% |
| Sutro Biopharma Inc | COM | 869367102 | $6.2M | 1,091,419 | 0.4% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $6.3M | 1,177,678 | 0.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $6.7M | 2,325,591 | 0.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $7.1M | 5,994,472 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $7.3M | 1,432,427 | 0.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $7.3M | 92,786 | 0.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $7.4M | 955,618 | 0.5% |
| Elevance Health Inc(ELV) | COM | 036752103 | $7.5M | 14,393 | 0.5% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $7.6M | 1,426,497 | 0.5% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $7.6M | 5,016,320 | 0.5% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $8.0M | 62,344 | 0.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.3M | 255,526 | 0.6% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $8.4M | 353,965 | 0.6% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $8.7M | 1,318,765 | 0.6% |
| Guardant Health Inc(GH) | COM | 40131M109 | $9.3M | 449,586 | 0.6% |
| Zimvie Inc(ZIMV) | COM | 98888T107 | $9.3M | 564,498 | 0.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $10.0M | 12,877 | 0.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $10.2M | 40,855 | 0.7% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $10.8M | 2,391,128 | 0.7% |
| Taro Pharmaceutical Inds LTD | SHS | M8737E108 | $11.2M | 263,541 | 0.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $11.9M | 411,478 | 0.8% |
| Humana Inc(HUM) | COM | 444859102 | $12.3M | 35,532 | 0.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $13.5M | 197,331 | 0.9% |
| Viatris Inc(VTRS) | COM | 92556V106 | $15.7M | 1,316,469 | 1.0% |